Definitive Contract HHSD200201691590C
Award Date
9/1/16
Potential Completion Date
9/30/18
Potential Value
$3M
Federal Agency
CDC Pittsburgh
Awardee
Vysnova Partners, LLC
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Available for Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,225,604 cost-plus-fixed-fee definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Vysnova Partners, LLC, a for-profit limited liability company, for ecological studies. The contract does not have a set-aside designation. Vysnova Partners is a professional services firm that specializes in medical research, clinical trials, disease surveillance, and global health initiatives for federal agencies. Through this contract, the company will provide...
This is a $10,047,532.00 definitive, cost-plus-fixed-fee contract awarded by the Centers for Disease Control and Prevention (CDC) to Vysnova Partners, LLC, a for-profit limited liability company, to conduct the Colombia Cohort Zika Study. The contract is not set aside. Vysnova Partners is a professional services firm that specializes in providing support for medical research, clinical trials, disease surveillance, and global health initiatives. The company holds several significant federal...
This is a cost-plus-fixed-fee delivery order contract awarded to Vysnova Partners, LLC, a for-profit limited liability company, by the Centers for Disease Control and Prevention (CDC) for professional services in Rwanda. The contract has a ceiling value of $1,355,294.54 and a completion date of April 22, 2025. Vysnova Partners is a prime contractor that specializes in providing professional, scientific, and technical services to federal agencies, with a focus on supporting medical research,...
This federal contract award was issued by the Defense Health Agency to Vysnova Partners, LLC, a for-profit limited liability company, to provide scientific, technical, and administrative support for infectious disease research and surveillance to identify and characterize medical threats to the warfighter. The contract has a ceiling value of $15,003,075.13 and a performance period through March 12, 2030. It is a cost-plus-fixed-fee delivery order contract, without a set-aside designation....
This federal contract award is for $1,359,200.46 to Vysnova Partners, LLC, a for-profit limited liability company, to provide strategic evaluation support services to the Defense Security Cooperation Agency (DSCA). The contract is a delivery order under the Assessment, Monitoring, and Evaluation Security Cooperation Support Services master IDIQ contract. Vysnova Partners has demonstrated expertise in providing professional, scientific, and technical services to federal agencies, particularly...
This is a delivery order awarded under the Defense Health Agency's authority to Vysnova Partners, LLC, a for-profit limited liability company, to provide medical readiness systems biology research support services. The $12,982,688.69 cost-plus-fixed-fee contract has a 5-year period of performance ending in November 2029 and is a total small business set-aside. Vysnova Partners is a federal contractor that specializes in supporting medical research, clinical trials, disease surveillance, and...
This is a firm-fixed-price delivery order contract awarded by the Defense Health Agency (DHA) to Vysnova Partners, LLC, a for-profit limited liability company. The contract, valued at $1,705,236.36, is for the provision of clinical research support services and is set aside for small businesses. Vysnova Partners is a federal contractor that specializes in providing professional, scientific, and technical services to various government agencies, with a focus on supporting medical research,...
This is a delivery order contract awarded by the U.S. Department of the Navy's Bureau of Medicine and Surgery (BUMED) to Vysnova Partners, LLC, a for-profit limited liability company. The contract, valued at $476,249.00, is for virus surveillance research and field services. The contract is a firm-fixed-price delivery order with a period of performance through September 27, 2025. Vysnova Partners has a history of providing medical research support, program management, and other professional...
This is a Cost Plus Fixed Fee contract awarded by the Centers for Disease Control and Prevention (CDC) to Vysnova Partners, LLC, a for-profit limited liability company, for a prospective, natural history study of SARS-CoV-2 infection in Wake Forest healthcare workers. The $54,179,237.36 contract was awarded on July 1, 2020 with a period of performance through February 28, 2023. The original solicitation was Broad Agency Announcement number 75D301-20-R-67897, which sought white papers from...
This is a $14,179,612.74 cost-plus-fixed-fee delivery order contract awarded to Vysnova Partners, LLC by the Defense Health Agency (DHA) to provide support for transitioning, implementing, and sustaining evidence-based research into practice to optimize the DHA's impact. The contract has a period of performance through July 2029 and is set aside for small businesses. Vysnova Partners is a for-profit limited liability company that specializes in providing professional, scientific, and technical...